Want to create an interactive transcript for this episode?
Podcast: Closer Look
Episode: In the fight against dementia, this will be a ‘transformational decade’
Description: Last week, Health Canada gave the green light to a long-awaited drug that slows the progression of early-stage Alzheimer’s disease.Lecanemab is the first approved medication that targets the buildup of amyloid plaque in the brain, believed to be an underlying cause of Alzheimer's.For patients and their loved ones across the country, the approval could not have come fast enough. According to the Alzheimer’s Society of Canada, there are close to 800,000 people in the country living with some form of dementia right now — a number that’s expected to hit 1 mi...